Suppr超能文献

感染与肝细胞癌:一项共病研究

infection and hepatocellular carcinoma: a comorbidity study.

作者信息

Allam Amal Farahat, Farag Hoda Fahmy, Shehab Amel Youssef, El Sahy Ahmed Soliman, Khalil Safia Saleh, El-Latif Naglaa Fathi Abd

机构信息

Department of Parasitology, Medical Research Institute, University of Alexandria, 165 El Horreya avenue, El Hadara, Alexandria, Egypt.

出版信息

J Parasit Dis. 2024 Dec;48(4):936-943. doi: 10.1007/s12639-024-01721-y. Epub 2024 Aug 21.

Abstract

BACKGROUND

The implication of human () infection in concomitance with other risk factors such as hepatitis C virus (HCV) and hepatitis B virus (HBV) in the development of hepatocellular carcinoma (HCC) is still under controversy. This work aimed. to evaluate the role of infection in association with hepatitis B virus (HBV), hepatitis C virus (HCV) and other risk factors in the development and/or progress of HCC.

METHODS

The present study was carried out on 90 HCC patients recruited from Kafr El-Sheikh Liver Disease Research Institute. After obtaining their informed consents, socio-demographic and clinical data were collected and patients were examined for by Kato-Katz and indirect hemagglutination (IHA) techniques. Alpha-fetoprotein (AFP) level was determined. The Child-Pugh scoring system and Barcelona Clinic Liver Cancer (BCLC) staging system were used to evaluate the pathological features of the studied patients.

RESULTS

All participants were negative for active by Kato-Katz. Based on IHA, the participants were categorized into two groups: group I: sixty-two patients negative for and group II: twenty-eight schistosomiasis positive. The patients' age ranged between 40->60, HCC was more prevalent in the age range of > 50-60 years in both groups. Males were more than females and rural participants were more than urban patients in both groups. Most of the patients (88.9%) had HCV while 7.8% had HBV. A higher proportion of HCC patients showed concomitant HCV and (92.6%) than the negative group. The frequency of upper gastrointestinal bleeding (GIB) was four-fold higher among HCC patients positive for schistosomiasis compared to negative schistosomiasis cases (64% vs. 16%). Alpha-fetoprotein (AFP) level was higher in group II than that in group I with no significant difference. Statistical analysis showed no difference between the two studied groups regarding Child scores. On the contrary, BCLC class D was significantly higher among HCC positive schistosomiasis cases compared to the negative group.

CONCLUSION

Concomitant with HCV and HBV potentiate HCC progression.

摘要

背景

人类()感染与丙型肝炎病毒(HCV)和乙型肝炎病毒(HBV)等其他危险因素同时存在时在肝细胞癌(HCC)发生发展中的影响仍存在争议。本研究旨在评估()感染与乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)及其他危险因素在肝细胞癌发生和/或进展中的作用。

方法

本研究对从卡夫尔谢赫肝病研究所招募的90例肝细胞癌患者进行。在获得他们的知情同意后,收集社会人口统计学和临床数据,并采用加藤厚涂片法和间接血凝试验(IHA)技术对患者进行()检测。测定甲胎蛋白(AFP)水平。采用Child-Pugh评分系统和巴塞罗那临床肝癌(BCLC)分期系统评估研究患者的病理特征。

结果

加藤厚涂片法检测显示所有参与者的()均为阴性。基于IHA,参与者被分为两组:第一组:62例()阴性患者;第二组:28例血吸虫病阳性患者。患者年龄在40->60岁之间,两组中HCC在>50-60岁年龄组更为常见。两组中男性均多于女性,农村参与者多于城市患者。大多数患者(88.9%)感染HCV,7.8%感染HBV。与()阴性组相比,HCC患者中同时感染HCV和()的比例更高(92.6%)。血吸虫病阳性的HCC患者上消化道出血(GIB)的发生率是血吸虫病阴性病例的四倍(64%对16%)。第二组的甲胎蛋白(AFP)水平高于第一组,但差异无统计学意义。统计分析显示,两组在Child评分方面无差异。相反,血吸虫病阳性的HCC病例中BCLC D期显著高于阴性组。

结论

()与HCV和HBV同时存在会促进HCC进展。

相似文献

1
infection and hepatocellular carcinoma: a comorbidity study.
J Parasit Dis. 2024 Dec;48(4):936-943. doi: 10.1007/s12639-024-01721-y. Epub 2024 Aug 21.
3
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340.
4
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD011645. doi: 10.1002/14651858.CD011645.pub2.
5
Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD011644. doi: 10.1002/14651858.CD011644.pub2.
6
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Direct-acting antivirals for chronic hepatitis C.
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD012143. doi: 10.1002/14651858.CD012143.pub2.
9
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

2
The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
Int J Biol Sci. 2022 Jan 1;18(2):536-551. doi: 10.7150/ijbs.64537. eCollection 2022.
3
infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.
Pathog Glob Health. 2022 Mar;116(2):119-127. doi: 10.1080/20477724.2021.1975081. Epub 2021 Sep 8.
4
Schistosomiasis and liver disease: Learning from the past to understand the present.
Clin Case Rep. 2020 May 22;8(8):1522-1526. doi: 10.1002/ccr3.2922. eCollection 2020 Aug.
6
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview.
J Egypt Natl Canc Inst. 2020 Jan 16;32(1):5. doi: 10.1186/s43046-020-0016-x.
7
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
J Clin Med. 2019 Oct 19;8(10):1736. doi: 10.3390/jcm8101736.
8
Egyptian liver library: An indexed database for liver disease evidence in Egypt.
Arab J Gastroenterol. 2019 Jun;20(2):109-113. doi: 10.1016/j.ajg.2019.05.004. Epub 2019 Jun 4.
9
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验